Meridian Bioscience DPO Ratio 2011-2026 | VIVO

Annual DPO Ratio Meridian Bioscience

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
37.2	37	36	31.9	27.5	37.1	40.8	33.3	25.3	30.2	33.2	33.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
40.8	25.3	33.6

Quarterly DPO Ratio Meridian Bioscience

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
57.8	-	-	34.1	32.6	-	42.9	44.9	39.7	15.3	37.9	28.9	35	10.8	32.7	30.8	28.6	9.22	28.9	33.8	36.5	12.3	37.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
57.8	9.22	31.5

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Agilent Technologies A	50.1	$ 110.24	-2.86 %	$ 33.5 B	USA
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Waters Corporation WAT	102	$ 289.16	-3.79 %	$ 17.2 B	USA
Exagen XGN	54.5	$ 2.68	-3.94 %	$ 57.8 M	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	49.2	-	-	$ 19.8 B	USA
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	125	$ 16.36	-11.57 %	$ 176 M	China
Sotera Health Company SHC	46.9	$ 13.13	-3.03 %	$ 3.73 B	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
BioNano Genomics BNGO	149	$ 1.16	0.87 %	$ 6.32 M	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	67.7	$ 62.25	-5.81 %	$ 24.3 B	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Castle Biosciences CSTL	52	$ 23.53	-4.74 %	$ 654 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	24.5	$ 159.16	-3.62 %	$ 7.89 B	USA
Quest Diagnostics Incorporated DGX	14.7	$ 195.51	-1.33 %	$ 21.7 B	USA
Organovo Holdings ONVO	82.9 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	95	-	-16.95 %	$ 1.54 M	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
PerkinElmer PKI	57.9	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	69	-	-	$ 21.2 M	USA
Interpace Biosciences IDXG	34.4	$ 1.68	-2.89 %	$ 7.37 M	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	62.7	$ 8.7	-4.92 %	$ 1.89 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	31.5	$ 264.2	-1.56 %	$ 22 B	USA
Psychemedics Corporation PMD	16	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	53	$ 25.97	-4.52 %	$ 33.7 M	USA
CareDx, Inc CDNA	44.2	$ 16.78	-3.95 %	$ 894 M	USA
Quotient Limited QTNT	86.2	-	-11.32 %	$ 1.1 M	Schweiz
Syneos Health SYNH	10.1	-	-	$ 4.46 B	USA
Renalytix AI plc RNLX	122	-	5.66 %	$ 22.7 M	Britain
Bioventus BVS	35.1	$ 8.94	-3.46 %	$ 596 M	USA
Co-Diagnostics CODX	106	$ 4.4	101.83 %	$ 129 M	USA
Danaher Corporation DHR	65.4	$ 181.52	-3.27 %	$ 129 B	USA
Surmodics SRDX	31.9	-	-	$ 608 M	USA
ENDRA Life Sciences NDRA	1.65 K	$ 4.29	-6.54 %	$ 2.3 M	USA